Ratnamani Metals & Tubes Limited (BOM:520111)

Inozyme Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	163,115	180,837	195,459	138,453	121,353	88,779
Market Cap Growth	-19.00%	-7.48%	41.17%	14.09%	36.69%	110.28%
Enterprise Value	160,917	182,409	195,050	137,812	118,284	84,735
Last Close Price	2327.15	2580.00	2777.47	1958.17	1706.88	1240.58
PE Ratio	28.08	33.24	31.39	27.12	37.61	32.17
PS Ratio	3.17	3.49	3.86	3.09	3.87	3.86
PB Ratio	4.45	4.93	6.08	5.17	5.40	4.47
P/TBV Ratio	4.52	5.01	6.26	5.36	5.40	4.47
P/FCF Ratio	-	87.30	65.55	82.13	-	21.36
P/OCF Ratio	-	33.72	38.23	44.59	-	16.27
EV/Sales Ratio	3.13	3.52	3.86	3.08	3.77	3.69
EV/EBITDA Ratio	18.73	22.15	21.79	17.81	23.98	21.28
EV/EBIT Ratio	21.50	25.48	24.39	19.91	28.53	24.71
EV/FCF Ratio	-	88.06	65.41	81.75	-	20.38
Debt / Equity Ratio	0.04	0.04	0.05	0.09	0.07	0.10
Debt / EBITDA Ratio	0.18	0.19	0.17	0.31	0.32	0.52
Debt / FCF Ratio	-	0.76	0.51	1.41	-	0.50
Asset Turnover	-	1.16	1.30	1.33	1.13	0.89
Inventory Turnover	-	2.36	2.57	2.50	2.57	2.12
Quick Ratio	-	1.68	2.06	1.37	1.33	2.56
Current Ratio	-	3.31	4.44	2.94	3.47	3.88
Return on Equity (ROE)	-	15.74%	21.22%	20.81%	15.23%	14.93%
Return on Assets (ROA)	-	10.02%	12.81%	12.83%	9.29%	8.31%
Return on Capital (ROIC)	13.01%	12.44%	15.91%	16.27%	11.27%	10.29%
Return on Capital Employed (ROCE)	-	18.30%	23.40%	23.70%	17.30%	15.70%
Earnings Yield	3.58%	3.01%	3.19%	3.69%	2.66%	3.11%
FCF Yield	-	1.15%	1.53%	1.22%	-3.52%	4.68%
Dividend Yield	0.60%	0.54%	0.50%	0.61%	0.55%	0.75%
Payout Ratio	-	18.04%	13.51%	12.81%	20.28%	-
Buyback Yield / Dilution	-0.47%	-0.46%	-	-	-	-
Total Shareholder Return	0.13%	0.08%	0.50%	0.61%	0.55%	0.75%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.